AMARIN CORP PLC\UK Operating Leases, Future Minimum Payments, Due in Two Years
AMARIN CORP PLC\UK (AMRN) had Operating Leases, Future Minimum Payments, Due in Two Years of $0 as of 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-02-27
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $0.00.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $156.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $126.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $505.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-27 |
| 2017-12-31 | $156.00K 10-K · filed 2018-02-27 |
| 2016-12-31 | $126.00K 10-K · filed 2017-03-01 |
| 2015-12-31 | $505.00K 10-K · filed 2016-02-25 |
| 2014-12-31 | $617.00K 10-K · filed 2015-03-03 |
| 2013-12-31 | $662.00K 10-K · filed 2014-02-27 |
| 2012-12-31 | $384.00K 10-K · filed 2013-02-28 |
| 2011-12-31 | $465.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |